Polypharmacy and Potentially Inappropriate Medications in Patients With Advanced Cancer: Prevalence and Associated Factors at the End of Life
Shoichi Masumoto, Takahiro Hosoi, Tõru Nakamura, Jun Hamano
Abstract
Medication reconciliation is recommended at the time of transition to a PCU or HMC, especially for older patients with advanced cancer who were referred from an outpatient setting and present more comorbidities and prescriptions.
Topics & Concepts
PolypharmacyMedicineIntensive care medicineCancerInternal medicinePharmaceutical Practices and Patient OutcomesPharmacological Effects and Toxicity StudiesPharmaceutical studies and practices